Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hezkue and Hezkue Turbo vs Commercial Sildenafil Products in ED
NCT07231185Phase 2Not yet recruiting
- Sponsor
- Aspargo Laboratories
- Start
- Jan 2026
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ASP-001 in erectile dysfunction (ED), sponsored by Aspargo Laboratories. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
ASP-001
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07231185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07231185.